FDA Drug Application (006917) for GANTRISIN by ROCHE

Back to FDA Applications sponsored by ROCHE

Application Number006917
Product Number001
FormINJECTABLE;INJECTION
DosageEQ 400MG BASE/ML
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameGANTRISIN
Active IngredientSULFISOXAZOLE DIOLAMINE

Active IngredientCount
List of drugs with Active Ingredient SULFISOXAZOLE7
List of drugs with Active Ingredient SULFISOXAZOLE ACETYL7
List of drugs with Active Ingredient SULFISOXAZOLE DIOLAMINE2


Back to FDA Applications sponsored by ROCHE